Introduction
============

Metastasis is the primary cause of death in breast cancer, and patient outcomes correlate negatively with the extent of metastatic spread at diagnosis ([@bib12]; [@bib46]). Metastasis initiates with dissemination, the escape of epithelial cancer cells from the primary tumor into the surrounding stroma ([@bib41]). As dissemination requires loss of epithelial cell--cell junctions, a change in the expression of intercellular adhesion genes could be the initiating event ([@bib39]; [@bib47]). Two related molecular models for dissemination have been proposed on this basis: genomic loss of cell adhesion genes ([@bib27]; [@bib12]; [@bib28]) and repression of cell adhesion genes through an epithelial to mesenchymal transition (EMT; [@bib45]; [@bib60]).

These molecular models converge on the cell adhesion gene *Epithelial cadherin* (*E-cad*; *Cdh1*). E-cad is essential for early embryonic development ([@bib31]); *E-cad* expression is frequently lost in human breast cancer ([@bib10]); and E-cad loss in experimental cancer models accelerates metastatic progression ([@bib17]; [@bib44]). However, a gap exists in our understanding of the relationship between the normal role of E-cad in adult tissues and its function during cancer metastasis. Analyses of E-cad's requirement in adult epithelial tissues using Cre-mediated deletion ([@bib13]) have revealed highly varied E-cad null phenotypes. Conditional *E-cad* deletion in the mammary gland results in cell death during lactation ([@bib13]), whereas conditional *E-cad* deletion in the skin results in hyperproliferation of some cell types and premature degeneration of others ([@bib52]). *E-cad* deletion in these developmental contexts is not associated with systemic dissemination. Nevertheless, transcriptional repression of *E-cad* by EMT transcription factors such as Twist1 remains a central concept in cancer metastasis ([@bib45]; [@bib60]). Twist1 regulates metastasis in a mouse mammary tumor model ([@bib61]), and its expression is up-regulated in both invasive lobular and invasive ductal breast cancer ([@bib61]; [@bib35]).

Collectively, previous publications have demonstrated that E-cad functions as an invasion suppressor and that induction of EMT transcription factors can accelerate malignant progression ([@bib27]; [@bib9]; [@bib12]; [@bib17]; [@bib60]; [@bib47]). However, human breast tumors typically contain thousands of mutations in both signaling and structural genes ([@bib59]; [@bib49]). These coexisting mutations obscure the contribution of individual genetic events to discrete steps in the metastatic cascade. Specifically, the presence of additional mutations in cancer cell lines has made it difficult to distinguish the individual sufficiency of *E-cad* deletion or *Twist1* expression for dissemination. Importantly, dissemination can be induced in developmental contexts such as neural crest migration, suggesting that its molecular regulation may be distinct from other aspects of neoplasia ([@bib7]).

We sought to define the minimum molecular perturbations necessary to induce dissemination of normal mammary epithelial cells. To accomplish these goals, we used a combination of organotypic culture, Cre-lox--based genetic models, inducible expression systems, lentiviral gene knockdown (KD), and time-lapse imaging to test the sufficiency of *E-cad* deletion or *Twist1* expression to induce dissemination in primary mammary epithelium. Our results demonstrate that E-cad is required for simple epithelial architecture and branching morphogenesis, but its loss is not associated with significant dissemination in 3D culture or in vivo. In contrast, *Twist1* expression induces rapid epithelial dissemination. Moreover, Twist1-induced dissemination occurs without loss of epithelial gene expression and requires E-cad.

Results
=======

E-cad is required for simple mammary epithelial architecture
------------------------------------------------------------

We first assayed the acute consequences of *E-cad* deletion in primary mammary epithelial cells using the "organoid" assay, in which mammary ducts are explanted into 3D ECM (Matrigel; [@bib20]; [Fig. 1 A](#fig1){ref-type="fig"}). In basal medium without growth factors, normal organoids form polarized cysts ([@bib20]; [Fig. 1, A and B](#fig1){ref-type="fig"}). We isolated organoids from mice carrying floxed *E-cad* alleles ([@bib13]) and a ubiquitously expressed, tamoxifen-inducible Cre recombinase ([@bib5]; *Cre-ER;E-cad^fl/fl^* mice). Organoids from the same mouse were divided into a control group and an experimental group in which *E-cad* deletion was induced with 50 nM tamoxifen.

![***E-cad* deletion induced loss of simple epithelial architecture.** (A) *E-cad* deletion was induced in half of *Cre-ER;E-cad^fl/fl^* organoids with tamoxifen. (B) Control, E-cad^+^ organoids (−Tam) formed cysts. (C) E-cad^−^ organoids (+Tam) failed to form cysts (28/42 movies across three biological replicates) or transiently established and then lost lumens (14/42 movies). (D) *E-cad* deletion blocked cyst formation. *n*, total number of organoids; *r*, number of biological replicates. Error bars indicate SD. \*\*\*, P = 0.0004, two-tailed Student's *t* test with equal variance. (E) Control organoids formed cysts with enrichment of E-cad and ZO-1 along apicolateral membranes (E'). (F) E-cad^−^ organoids were multilayered, lacked E-cad immunoreactivity, and displayed abnormal ZO-1 localization. Arrow indicates rare E-cad^+^ cells. (G) By Western blot, *E-cad* deletion (+Tam) resulted in complete loss of E-cad protein and significant reductions in αE-catenin and β-catenin (see also [Fig. S1, A and B](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp1}). Whole cell lysate samples were loaded for equal protein based on BCA analysis. (H) The Cre biosensor *mT/mG* was used to observe E-cad^−^ cell behaviors by confocal microscopy ([Video 1](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp2}). Cre^+^, E-cad^−^ cells (green) changed shape, from columnar to round, before shifting apically (H' and H'', arrowheads). Gamma adjustments were performed in E and F to improve image clarity. Bars: (B and C) 20 µm; (E, F, and H) 10 µm.](JCB_201306088_Fig1){#fig1}

Control organoids efficiently formed polarized cysts, with E-cad localized to lateral points of cell--cell contact and zona occludens 1 (ZO-1) localized in apical puncta (58.2%; [Fig. 1, B, D, E, and E′](#fig1){ref-type="fig"}). In contrast, E-cad^−^ organoids either failed to establish simple epithelial architecture (66%) or transiently established and then lost simple epithelial architecture (33%; [Fig. 1, C and D](#fig1){ref-type="fig"}). E-cad^−^ organoids had a multilayered organization and lacked morphologically evident lumens ([Fig. 1, E and F](#fig1){ref-type="fig"}). Interestingly, a subset of lateral cell--cell contact surfaces within E-cad^−^ organoids had continuous ZO-1 staining ([Fig. 1, F and F′](#fig1){ref-type="fig"}). Immunofluorescence ([Fig. 1 F](#fig1){ref-type="fig"}) and Western blotting ([Fig. 1 G](#fig1){ref-type="fig"}) confirmed loss of E-cad protein by day 6 in culture. E-cad loss coincided with a reduction in αE-catenin and β-catenin ([Fig. 1 G](#fig1){ref-type="fig"}) but not with a significant change in neural cadherin (N-cad; [Fig. S1, A and B](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp3}). By immunofluorescence, αE-catenin was absent from most internal cell--cell contact surfaces (Fig. S1, C--C″).

E-cad^−^ cells are excluded from regions of simple epithelial organization but rarely disseminate
-------------------------------------------------------------------------------------------------

We next used time-lapse microscopy to observe the cell dynamics driving loss of simple organization after *E-cad* deletion. We monitored recombined cells using the genetically encoded Cre biosensor *mT/mG* ([@bib38]). Without Cre activity, all cells in *mT/mG* mice express a membrane-localized red fluorescent protein. Cre activity excises the red gene and induces heritable expression of a membrane-localized green fluorescent protein. We could thereby distinguish in real-time the behaviors of E-cad^+^ (red) versus E-cad^−^ (green) cells. Loss of simple epithelial architecture in E-cad^−^ organoids correlated with a reduction in luminal volume ([Fig. 1 H](#fig1){ref-type="fig"} and [Video 1](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp4}), consistent with a loss of tight junctions. This tissue-level change was accompanied by a change in E-cad^−^ cell shape from simple columnar to round ([Fig. 1, H′ and H″](#fig1){ref-type="fig"}). Round cells shifted internally, inducing a transition from a single to multiple luminal epithelial cell layers ([Fig. 1, H′ and H″](#fig1){ref-type="fig"}, arrowheads).

We next monitored whether *E-cad* deletion was sufficient to induce dissemination into the ECM. Normal epithelial cysts maintain a smooth basal surface with the ECM ([Fig. 2 A](#fig2){ref-type="fig"}). Conversely, E-cad^−^ cells accumulated on the basal surface and collectively migrated into Matrigel as single file columns ([Fig. 2, B, B′, G, and G′](#fig2){ref-type="fig"}) and as disorganized masses ([Fig. 2, E, E′, F, and F′](#fig2){ref-type="fig"}). Single file migration initiated from basally positioned E-cad^−^ cells that rounded up but maintained cell--cell contact ([Fig. 2 C](#fig2){ref-type="fig"}). As additional cells changed shape, the initiating cell migrated further into the ECM and led a column of closely connected E-cad^−^ cells. However, despite contact with the ECM and high motility, E-cad^−^ cells rarely disseminated into the matrix. Each organoid consists of 300--500 cells; yet, on average, only one cell disseminated from each E-cad^−^ organoid (*n* = 206 organoids imaged by time-lapse microscopy across nine biologically independent replicates). Most E-cad^−^ cells remained adherent to other epithelial cells. The few E-cad^−^ cells that did disseminate were rounded, migrated minimally, and had no detectable membrane protrusions.

![**E-cad^−^ cells displayed reductions in multiple classes of intercellular junctions.** *Cre-ER;E-cad^fl/+^* and *Cre-ER;E-cad^fl/fl^* organoids were isolated, and widespread recombination was induced with tamoxifen. (A) Control organoids (E-cad^+^) maintained a smooth basal epithelial border. (B) E-cad^−^ organoids collectively migrated into Matrigel as single file columns (B', red arrowhead). (C) Basally positioned E-cad^−^ cells (white arrowhead) were observed to round up and initiate single file cell columns. (D) Adeno-Cre was used to generate genetic mosaic organoids with a mixture of E-cad^+^ and E-cad^−^ cells. (E and F) Green, Cre^+^ cells reliably lacked E-cad (E and E') and β-catenin (F and F'). (G) Basally positioned E-cad^−^ cells were located beyond the basement membrane protein laminin 332. Arrows in G′ indicate a single file column. (H) TEM was used to quantify desmosomes in Adeno-Cre--transduced *E-cad^fl/+^* (control) and *E-cad^fl/fl^* organoids. Red outline indicates a representative region used for analysis. (I) E-cad^−^ epithelium had significantly fewer desmosomes compared with control E-cad^+^ epithelium. Error bars indicate SD. \*\*\*, P = 0.0008; two-tailed Student's *t* test with equal variance. (J) Small desmosomes (J', yellow arrowheads) were detected connecting cells in single file columns. Gamma adjustments were performed in E and F to improve image clarity. Bars: (A and B) 20 µm; (C and E--G) 10 µm; (H) 5 µm; (J) 0.5 µm. The black rectangle in the top right corner of J is a region of the image mosaic where no pixels were collected.](JCB_201306088R_Fig2){#fig2}

E-cad^−^ cells remain adherent despite reductions in multiple classes of intercellular junctions
------------------------------------------------------------------------------------------------

To analyze the effects of mosaic E-cad loss, we used adenovirally delivered Cre (Adeno-Cre) to induce *E-cad* deletion in a subset of cells within *E-cad^fl/fl^;mT/mG* organoids ([Fig. 2 D](#fig2){ref-type="fig"}). We confirmed that green, Cre^+^ cells stained negative for E-cad protein ([Fig. 2, E and E′](#fig2){ref-type="fig"}) and that loss of E-cad was accompanied by loss of β-catenin from the membrane ([Fig. 2, F and F′](#fig2){ref-type="fig"}). In these genetic mosaic organoids, E-cad^−^ cells were observed both basally at the cell--ECM interface and in interior positions apical to polarized E-cad^+^ cells ([Fig. 2, D--F](#fig2){ref-type="fig"}). The basally positioned E-cad^−^ cells were frequently observed past the cell-derived basement membrane (laminin 332 immunofluorescence; [Fig. 2, G and G′](#fig2){ref-type="fig"}). E-cad^+^ cells within the same organoid localized β-catenin to points of cell--cell contact and were inside the basement membrane ([Fig. 2, E--G](#fig2){ref-type="fig"}).

We next sought to identify adhesion systems that could allow epithelial cells to remain adherent despite loss of E-cad and membrane-localized β-catenin. Desmosomes represent a major class of intercellular junctions in mammary epithelial cells ([@bib11]). However, E-cad inhibition can induce reductions in both desmosomes and tight junctions ([@bib24]). We therefore used transmission electron microscopy (TEM) to quantify the effect of E-cad loss on intercellular junctions in organoids from *E-cad^fl/fl^* and *E-cad^fl/+^* littermates. We induced recombination with Adeno-Cre and focused our analysis on basally positioned cells ([Fig. 2 H](#fig2){ref-type="fig"}). E-cad^−^ cells typically lacked both punctate ZO-1 immunoreactivity ([Fig. 1 F](#fig1){ref-type="fig"}) and ultrastructurally identifiable tight junctions. Compared with normal E-cad^+^ epithelium, E-cad^−^ epithelium also had a statistically significant, almost eightfold reduction in desmosomes ([Fig. 2 I](#fig2){ref-type="fig"}). However, we still detected small desmosomes connecting E-cad^−^ cells, even within single file migration columns ([Fig. 2, J and J′](#fig2){ref-type="fig"}). Collectively, our data reveal that loss of E-cad results in loss of simple epithelial architecture, reductions in multiple classes of cell--cell junctions, and both apical and basal exclusion of E-cad^−^ cells from E-cad^+^ simple epithelium. However, E-cad loss was not sufficient for robust single cell dissemination into the 3D ECM.

E-cad is required for branching morphogenesis in 3D culture
-----------------------------------------------------------

Normal mammary branching morphogenesis begins with a transition from simple to multilayered architecture and a concurrent reduction in apicobasal polarity and intercellular junctions ([@bib20], [@bib22]). Therefore, it was plausible that E-cad^−^ cells could participate in branching morphogenesis. We thus assayed the effects of *E-cad* deletion under culture conditions that use FGF2 to induce branching morphogenesis ([@bib20]; [Fig. 3 A](#fig3){ref-type="fig"}).

![**Loss of E-cad inhibited branching morphogenesis and induced epithelial disorganization in 3D culture.** (A) *E-cad^+/+^;mT/mG* and *E-cad^fl/fl^;mT/mG* organoids were isolated, recombination was induced with Adeno-Cre, and branching morphogenesis was induced with FGF2. (B) E-cad^+^ organoids completed branching morphogenesis ([Video 2](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp5}). (C) E-cad^−^ organoids developed a disorganized basal surface composed of rounded cells (C'; Video 2). (D) This disorganized surface morphology was observed in 94% of E-cad^−^ organoids. *n*, number of time-lapse movies; *r*, number of biological replicates. (E and F) Basally positioned cells were green (Cre^+^), E-cad^−^ (E), and β-catenin^−^ (F). (G and H) In genetic mosaic organoids with a mixture of E-cad^+^ and E-cad^−^ cells, E-cad^+^ cells (red) were observed to initiate new buds (arrowheads; H'; [Video 3](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp6}). Bars: (B and C) 20 µm; (E, F, and H) 10 µm.](JCB_201306088_Fig3){#fig3}

We first induced *E-cad* deletion in most epithelial cells using Adeno-Cre and monitored effects on branching by time-lapse microscopy. Control E-cad^+^ organoids underwent normal branching morphogenesis ([Fig. 3 B](#fig3){ref-type="fig"} and [Video 2](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp7}). Specifically, they initiated and elongated numerous mammary buds and maintained a smooth border with the ECM. In contrast, E-cad^−^ organoids did not undergo branching morphogenesis and instead rapidly developed a disorganized and uneven basal epithelial surface ([Fig. 3, C and D](#fig3){ref-type="fig"}; and Video 2). Cells at the basal ECM border were rounded and displayed extensive, uncoordinated motility ([Fig. 3 C′](#fig3){ref-type="fig"}). These cells were Cre biosensor^+^ (green) and E-cad^−^ by immunofluorescence ([Fig. 3, E and E′](#fig3){ref-type="fig"}) and lacked β-catenin at points of cell--cell contact ([Fig. 3, F and F′](#fig3){ref-type="fig"}).

We next induced genetic mosaic *E-cad* deletion and observed some normal, smooth epithelial buds emerging from disorganized cell surfaces. We hypothesized that these buds were composed of E-cad^+^ cells that had escaped recombination ([Fig. 3 G](#fig3){ref-type="fig"}). Consistent with this model, we observed groups of red, E-cad^+^ cells coalesce and initiate new buds from within large disorganized groups of green, E-cad^−^ cells ([Fig. 3, H and H′](#fig3){ref-type="fig"}; and [Video 3](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp8}). Our data demonstrate that E-cad^−^ cells remain motile and adherent but fail to incorporate into epithelial buds. Furthermore, in genetic mosaic mixtures, E-cad^+^ cells can initiate buds from predominantly E-cad^−^ organoids ([Fig. 3, G and H](#fig3){ref-type="fig"}).

E-cad^−^ cells are excluded from polarized ducts and the body cell compartment of the terminal end bud (TEB) in vivo
--------------------------------------------------------------------------------------------------------------------

Our genetic mosaic analysis in 3D culture revealed that E-cad^−^ cells lost simple epithelial architecture and most intercellular junctions but remained adherent to each other. However, the presence of E-cad^−^ cells in an organoid did not prevent the initiation of E-cad^+^ epithelial buds. Accordingly, we predicted that, in vivo, genetic mosaic *E-cad* deletion would result in exclusion of E-cad^−^ cells from regions of active branching morphogenesis and accumulation of disorganized E-cad^−^ cell groups both apically and basally. To test this prediction, we isolated organoids from control *E-cad^+/+^;mT/mG* mice and from *E-cad^fl/fl^;mT/mG* mice, induced mosaic recombination with Adeno-Cre, and transplanted the organoids into contralateral, cleared mammary fat pads of 3-wk-old NOD/SCID mice ([Fig. 4, A and D](#fig4){ref-type="fig"}, respectively). Glands were harvested and analyzed 6 wk after transplantation.

![**E-cad^−^ cells were excluded from polarized ducts and the body cell compartment of the TEB in vivo.** (A) Adeno-Cre--transduced *mT/mG* organoids (E-cad^+^) were transplanted into cleared mammary fat pads, and glands were harvested after 6 wk. (B and C) Both TEBs (B) and polarized ducts (C) contained a mixture of red and green cells in the luminal and myoepithelial cell layers. (D) Adeno-Cre--transduced *E-cad^fl/fl^;mT/mG* organoids were transplanted into contralateral no. 4 glands. (E) E-cad^−^ luminal cells were markedly excluded from the body cell region of the TEB in ductal outgrowths. Arrowheads indicate green cells in the cap cell layer. (F and G) E-cad^−^ luminal cells were observed on the basal surfaces of polarized epithelium in the gland periphery (F) and near the injection site (G). (H) E-cad^−^ cells were also observed in disorganized clusters surrounded by myoepithelial cells (H', SMA^+^). (I) *Cre-ER;E-cad^fl/fl^;mT/mG* organoids (E-cad^+^) were transplanted into cleared mammary fat pads and allowed to grow out for 6 wk. Tamoxifen was injected to induce *E-cad* deletion, and glands were harvested after 2--6 wk. (J) E-cad^−^ cells were observed in the lumens (J') and on the basal surfaces (J'') of E-cad^+^ polarized ducts (nine glands). Bars, 10 µm.](JCB_201306088_Fig4){#fig4}

Mammary ducts during puberty are elongated by specialized epithelial structures known as TEBs ([@bib58]). TEBs are composed of a single, basally positioned layer of cap cells and multiple, apically positioned body cell layers ([@bib26]). Cap cells give rise to myoepithelial lineages, whereas body cells give rise to luminal epithelial lineages. Only body cells express *E-cad* ([@bib16]). Ductal outgrowths from control, genetic mosaic *mT/mG* transplants had both red and green cells in the body and cap cell regions of the TEB ([Fig. 4, B and B′](#fig4){ref-type="fig"}) and in the luminal and myoepithelial cell layers of polarized ducts ([Fig. 4, C and C′](#fig4){ref-type="fig"}). In contrast, outgrowths from genetic mosaic *E-cad^fl/fl^;mT/mG* transplants displayed a striking exclusion of E-cad^−^ cells from the body cell region of the TEB ([Fig. 4, E and E′](#fig4){ref-type="fig"}) and from the luminal layer of ducts ([Fig. 4, F and F′](#fig4){ref-type="fig"}). Myoepithelial cells were red and green in *E-cad^fl/fl^;mT/mG* genetic mosaic outgrowths ([Fig. 4 E′](#fig4){ref-type="fig"}, green arrowheads), but myoepithelial cells express *P-cadherin* instead of *E-cad* ([@bib16]).

Despite their exclusion from polarized ducts and body cells, E-cad^−^ cells were observed in vivo at 6 wk after transplantation. Groups of E-cad^−^ cells were detected on the basal surfaces of polarized E-cad^+^ ducts in the gland periphery ([Fig. 4, F and F′](#fig4){ref-type="fig"}) and on the basal surfaces of polarized E-cad^+^ epithelium near the transplantation site ([Fig. 4, G and G′](#fig4){ref-type="fig"}). We also observed small clusters of exclusively E-cad^−^ cells, surrounded by myoepithelial cells (smooth muscle actin^+^ \[SMA\]; [Fig. 4, H and H′](#fig4){ref-type="fig"}). Consistent with our 3D culture data, green, Cre^+^ cells in vivo were validated by antibody staining to lack membrane-localized E-cad (Fig. S1, D--F) and β-catenin (Fig. S1G).

We next tested the in vivo consequences of *E-cad* deletion in polarized mammary epithelium. We isolated and transplanted organoids from *Cre-ER;E-cad^fl/fl^;mT/mG* mice into cleared mammary fat pads, waited 6 wk for mature ductal outgrowths, and induced *E-cad* deletion by tamoxifen injection ([Fig. 4 I](#fig4){ref-type="fig"}). Glands were harvested and analyzed 2--6 wk after tamoxifen injection. E-cad^−^ cells (by immunofluorescence) were observed apically inside duct lumens ([Fig. 4, J and J′](#fig4){ref-type="fig"}) and basally as single cells or disorganized groups on duct surfaces ([Fig. 4, J and J″](#fig4){ref-type="fig"}). Basally positioned E-cad^−^ cells were typically still surrounded by myoepithelial cells.

We conclude that E-cad is required in mammary epithelial cells to establish and maintain simple epithelial architecture and to initiate and elongate new buds, both in 3D culture and in vivo. E-cad^−^ cells are viable in both contexts but extrude apically and basally from polarized epithelium and fail to contribute to mammary branching morphogenesis in the luminal cell compartment.

Twist1 induces robust cell dissemination of otherwise normal primary epithelial cells
-------------------------------------------------------------------------------------

Our data reveal that E-cad loss is not sufficient for robust cell dissemination in 3D culture or in vivo. This conclusion has implications for our conceptual understanding of EMT, as repression of *E-cad* is considered a core effector of EMT ([@bib61]; [@bib45]; [@bib56]; [@bib51]). The bHLH transcription factor Twist1 has emerged as a candidate regulator of EMT in cancer and is thought to act through regulation of *E-cad* ([@bib61]; [@bib56]; [@bib60]). We sought to test the hypothesis that acute expression of *Twist1* would induce epithelial dissemination.

We isolated organoids from mice carrying a ubiquitously expressed reverse tetracycline transactivator (rtTA) and a Tet-responsive *Twist1* allele ([Fig. 5 A](#fig5){ref-type="fig"}, *CMV::rtTA;TRE-Twist1*; [@bib53]). In basal medium, control organoids maintained a smooth basal surface ([Fig. 5 B](#fig5){ref-type="fig"}). In contrast, *Twist1* expression induced rapid dissemination of protrusive, individual cells out of the epithelium as early as 24 h after *Twist1* induction ([Fig. 5, C and C′](#fig5){ref-type="fig"}; and [Video 4](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp9}). We next tested the relationship between branching morphogenesis and dissemination. In FGF2-containing medium, control organoids branched efficiently ([Fig. 5 D](#fig5){ref-type="fig"}). In contrast, *Twist1* expression inhibited FGF2-induced branching morphogenesis in 99% of organoids and induced robust dissemination in 97% of organoids ([Fig. 5, D--F](#fig5){ref-type="fig"}; and [Video 5](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp10}). In the presence of FGF2, disseminated cells proliferated to form secondary epithelial sites within the ECM ([Fig. 5 E′](#fig5){ref-type="fig"}). Immunofluorescent staining for cell type--specific cytokeratins revealed that both luminal epithelial (K8^+^) and myoepithelial (K14^+^) cells disseminated in response to *Twist1* induction ([Fig. 5 G](#fig5){ref-type="fig"}). Interestingly, both cells within the epithelial structure and disseminated cells dislayed nuclear Twist1 immunoreactivity ([Fig. 5, H and H′](#fig5){ref-type="fig"}). The Twist1^+^ epithelial group displayed abnormal internal localization of myoepithelial cells (SMA^+^) and basement membrane (laminin 332) and corresponding gaps in basal myoepithelial and basement membrane coverage ([Fig. 5 I](#fig5){ref-type="fig"}).

![**Twist1 induced robust dissemination of normal epithelial cells.** (A) Organoids were isolated from *CMV::rtTA;TRE-Twist1* mice, and *Twist1* was induced in half of the organoids with doxycycline. (B and C) In basal medium, control organoids maintained epithelial organization (B), whereas *Twist1* expression induced robust dissemination (C; [Video 4](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp11}). Disseminating cells (red arrowheads) migrated away from the epithelium with extensive protrusions (C'). (D and E) In FGF2-containing medium, control organoids completed branching morphogenesis (D), whereas *Twist1* expression blocked branching and induced robust dissemination (E; [Video 5](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp12}). Red arrowheads in E indicate disseminated cells. With FGF2, disseminated cells proliferated to form secondary epithelial sites (blue arrows; E'; 6/9 biological replicates). (F) Less than 1% of Twist1^+^ organoids branched (\*\*\*, P = 0.0006, two-tailed Student's *t* test with equal variance), whereas 97% disseminated (\*\*\*\*, P = 4 × 10^−7^, two-tailed Student's *t* test with equal variance). *n,* total number of organoids; *r*, number of biological replicates. Error bars indicate SD. (G) Both luminal (K8^+^; red arrows) and myoepithelial (K14^+^; green arrows) cells disseminated. (H) Both disseminated single cells and cells within the main epithelial group were Twist1^+^. (I) Myoepithelial cells (SMA^+^) and basement membrane (laminin 332; arrows) were inappropriately localized to the organoid interior. Gamma adjustments were performed in H, H′, and I to improve image clarity. Bars: (B--E) 20 µm; (G--I) 10 µm.](JCB_201306088_Fig5){#fig5}

Epithelial cell behaviors are restored when *Twist1* expression is turned off
-----------------------------------------------------------------------------

We next tested the consequences of transient expression of *Twist1*. We induced *Twist1* for 48 h and then turned off *Twist1* by removing doxycycline ([Fig. 6 A](#fig6){ref-type="fig"}). In basal medium, disseminated single cells stopped migrating within 48 h of doxycycline removal ([Fig. 6, B and B′](#fig6){ref-type="fig"}; and [Video 6](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp13}). In FGF2-containing medium, organoids initiated branching morphogenesis within 70 h of doxycycline removal ([Fig. 6, C and D](#fig6){ref-type="fig"}; and [Video 7](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp14}), and disseminated single cells were observed reintegrating with the epithelial group ([Fig. 6 E](#fig6){ref-type="fig"}). Remarkably, by day 7, the resulting branched structures had normalized epithelial organization, with internal luminal cells and basally positioned myoepithelial cells ([Fig. 6 F](#fig6){ref-type="fig"}). We conclude that epithelial cells can rapidly reestablish normal developmental programs, such as branching morphogenesis, when *Twist1* expression ceases.

![**Organoids recovered epithelial behaviors when *Twist1* was turned off.** (A) *Twist1* was transiently activated in *CMV::rtTA;TRE-Twist1* epithelium by a 48-h pulse of doxycycline. (B) In basal medium, organoids transiently disseminated, but disseminated cells stopped migrating after doxycycline removal (arrowheads; [Video 6](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp27}). (C--E) In the presence of FGF2, organoids initiated new buds after doxycycline removal (D), and disseminated cells reintegrated with the main organoid (E; [Video 7](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp28}). (F) Branched organoids displayed normal mammary epithelial organization, with inner luminal epithelial cells (K8^+^) and outer myoepithelial cells (K14^+^). Bars, 20 µm.](JCB_201306088_Fig6){#fig6}

Twist1-induced dissemination is cell autonomous
-----------------------------------------------

We demonstrated that ubiquitous *Twist1* activation induced rapid epithelial dissemination. We next sought to test whether a single Twist1^+^ cell could escape a mostly Twist1^−^ epithelium. We reasoned that Twist1^−^ cells could serve as a barrier to dissemination. Alternatively, Twist1^+^ cells could induce the dissemination of neighboring Twist1^−^ cells. To achieve mosaic activation of *Twist1*, we used a *Lox-Stop-Lox-rtTA* (*R26::LSL-rtTA* \[[@bib8]\]) and varying titers of Adeno-Cre to modulate the fraction of cells capable of activating *Twist1*. We again used the *mT/mG* reporter ([@bib38]) to distinguish between Cre^+^rtTA^+^ (green) and Cre^−^rtTA^−^ (red) cells. We monitored the resulting genetic mosaic tissue for dissemination in our branching morphogenesis assay ([Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp15}).

Without doxycycline or *Twist1* induction, organoids formed branched structures with a mix of red and green cells (Fig. S2 B). Conversely, *Twist1* induction resulted in dissemination of green (Cre^+^rtTA^+^Twist1^+^) cells across a wide range of viral titers, even in organoids in which most cells were Cre^−^rtTA^−^Twist1^−^ (Fig. S2, C and D). Epithelium that was mostly Twist1^−^ had a high frequency of branching morphogenesis despite the dissemination of Twist1^+^ cells (Fig. S2 E). As the fraction of rtTA^+^Twist1^+^ cells per organoid increased, we observed a decrease in the percentage of branching organoids (Fig. S2 E), consistent with the branching inhibition observed in epithelium with constitutive *Twist1* expression ([Fig. 5 F](#fig5){ref-type="fig"}). We never observed dissemination of red, rtTA^−^ cells, indicating that Twist1-induced dissemination is cell autonomous.

Twist1 is sufficient to induce local dissemination in vivo
----------------------------------------------------------

Our 3D culture data predicted that Twist1 would induce epithelial dissemination in vivo. To test this prediction, we transplanted genetic mosaic organoids containing a mixture of red, Twist1^−^ and green, Twist1^+^ cells into cleared mammary fat pads of 3-wk-old NOD/SCID mice (Fig. S2 F). *Twist1* was induced in culture and maintained in vivo using doxycycline feed. Consistent with our 3D culture data, we observed local dissemination of green, Twist1^+^ cells into the surrounding stroma (Fig. S2, G--G″). We did not detect dissemination of red, Twist1^−^ cells. Importantly, we observed groups of 10--20 green, Twist1^+^ epithelial cells in the stroma (Fig. S2, H and H′). We hypothesize that these groups represent secondary epithelial sites formed from disseminated Twist1^+^ cells. We conclude that *Twist1* expression is sufficient for epithelial dissemination in 3D culture and in vivo.

Twist1 induces dissemination without complete loss of adherens junction components
----------------------------------------------------------------------------------

Our genetic analyses revealed that loss of E-cad and expression of *Twist1* induced distinct cell behaviors and tissue-level phenotypes. *E-cad* deletion resulted in loss of polarized epithelial architecture, whereas *Twist1* expression induced dissemination of luminal and myoepithelial cells ([Fig. 7, A--G](#fig7){ref-type="fig"}). We next used immunoblotting to compare levels of cell--cell adhesion proteins between normal (−Dox) and *Twist1*-expressing (+Dox) tissue. We observed significant reductions in E-cad, αE-catenin, β-catenin, and N-cad ([Fig. 7 H](#fig7){ref-type="fig"} and [Fig. S3, A and B](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp16}) but detected protein in all cases. This reduction in N-cad is inconsistent with a cadherin switch model in which increases in N-cad levels induce migration ([@bib43]). We next used immunofluorescence to localize E-cad and β-catenin during dissemination. Consistent with our Western blot results, E-cad staining appeared weaker in cells expressing *Twist1*. However, we observed E-cad and β-catenin localized at points of cell--cell contact in cells before dissemination ([Fig. 7, I and L](#fig7){ref-type="fig"}); E-cad and β-catenin localized to the rear of recently disseminated cells ([Fig. 7, J and M](#fig7){ref-type="fig"}); and E-cad and β-catenin localized to the membranes of cells migrating in the ECM ([Fig. 7, K and N](#fig7){ref-type="fig"}). We also observed E-cad^−^ cells in the matrix, consistent with the dissemination of K14^+^ myoepithelial cells, which would not normally express E-cad. We conclude that Twist1 can induce dissemination of cells with membrane-localized adherens junction proteins.

![**Twist1 induced single cell dissemination despite membrane-localized adherens junction proteins.** (A and B) *E-cad* deletion blocks branching and induces epithelial disorganization. (C) Rare E-cad^−^ disseminated cells maintain a rounded morphology. (D and E) *Twist1* expression blocks branching and induces single cell dissemination (red arrowheads). (F) Disseminated Twist1^+^ cells exhibit extensive actin-rich protrusions (red arrows). (G) In time-lapse movies, E-cad^−^ cells were only rarely observed to disseminate. In contrast, \>100 cells per Twist1^+^ organoid were routinely observed to disseminate. *n,* number of time-lapse movies; *r*, number of biological replicates. (H) By Western blot, *Twist1* expression resulted in reductions in protein levels of E-cad, N-cad, αE-catenin, and β-catenin (see also [Fig. S3, A and B](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp17}). Whole cell lysate samples were loaded for equal protein based on BCA analysis. (I--N) Membrane-localized E-cad and β-catenin (arrowheads) were detected in basally positioned cells protruding into the ECM (I and L), in cells that had just disseminated (J and M), and in disseminated cells migrating through the ECM (K and N). Bars: (B and E) 20 µm; (C, F, and I--N) 10 µm.](JCB_201306088_Fig7){#fig7}

Twist1 induces transcriptional changes in cell--matrix adhesion but does not fundamentally alter epithelial identity
--------------------------------------------------------------------------------------------------------------------

We next sought to identify the early transcriptional changes downstream of *Twist1*. We isolated organoids from three *CMV::rtTA;TRE-Twist1* mice and three rtTA^−^ littermate controls (*TRE-Twist1*), cultured these organoids for 24 h in basal medium, added doxycycline for 48 h, and then extracted RNA during active dissemination ([Fig. 8 A](#fig8){ref-type="fig"}). RNA-seq analysis identified 183 genes that were differentially expressed between control and *Twist1*-expressing tissue at genome-wide significance (P = 2.7 × 10^−6^; [Table S1](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp18}).

![**Twist1 induced changes in genes regulating cell--ECM interactions and the extracellular space.** (A) RNA-seq was used to compare gene expression 48 h after *Twist1* induction in control versus Twist1^+^ organoids. (B) Heat map of canonical EMT genes. Only *Twist1* was significantly differentially expressed. Genes are sorted by increasing p-value. (C--F) The 183 DE genes were mapped to direct associations with GO Slim biological process (C) and cellular component (E) terms. Black vertical bars indicate the expected number of DE genes per category. Asterisks specify significantly enriched terms. (D) DE genes associated with cell adhesion. (F) DE genes associated with extracellular space, extracellular region, and proteinaceous ECM. Genes are sorted by descending fold change in D and F. BP, biological process; CC, cellular component.](JCB_201306088_Fig8){#fig8}

Surprisingly, none of the canonical EMT genes were significantly differentially expressed at the RNA level, including *E-cad* (P = 0.35). However, both *Snai1* (P = 3.2 × 10^−6^) and *Fn1* (P = 4.6 × 10^−6^) were close to genome-wide significance ([Fig. 8 B](#fig8){ref-type="fig"}). We next analyzed the expression of 127 genes involved in cell--cell adhesion and intercellular junctions ([Table S2](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp19}). Of these genes, only five were differentially expressed (*Celsr1*, *Cldn2*, *Fat4*, *Frem2*, and *Pcdh18*). No classical cadherins, desmosomal cadherins, catenins, or cytokeratins were significantly dysregulated at the RNA level. We conclude that Twist1 induces dissemination without loss of epithelial identity. This observation is consistent with the positive immunoreactivity for cytokeratin, E-cad, and β-catenin protein in disseminated cells.

We next analyzed gene ontology (GO) slim annotations to characterize biological process ([Fig. 8 C](#fig8){ref-type="fig"}), cellular component ([Fig. 8 E](#fig8){ref-type="fig"}), and molecular function terms ([Fig. S5A](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp20}) associated with our 183 differentially expressed (DE) genes ([@bib4]). Relevant GO biological processes with several DE genes included cell adhesion ([Fig. 8 D](#fig8){ref-type="fig"}), transport ([Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp21}), cell differentiation (Fig. S4 B), lipid metabolic process (Fig. S4 C), and signal transduction (Fig. S4 D). Of these, the cell adhesion, cell differentiation, and ECM organization GO categories were statistically significantly enriched for DE genes relative to genes overall. Importantly, the DE cell adhesion genes were primarily associated with cell--substrate, not cell--cell, adhesion and with cell migration, cell projections, and ECM organization ([Fig. 8 D](#fig8){ref-type="fig"}). We observed significantly more DE genes than expected in GO cellular component categories for extracellular region, extracellular space, and proteinaceous ECM ([Fig. 8 F](#fig8){ref-type="fig"}). DE genes were also associated with the cytoplasm (Fig. S4 E), plasma membrane (Fig. S4 F), and nucleus.

To complement the GO analysis of DE genes at genome-wide significance, we also performed a more general test of differential expression. Because we observed discordant expression changes within pathways, we used a joint test of up- and down-regulation by calculating the absolute value of the *z*-score for differential expression of each gene, followed by a *t* test for genes within versus outside each pathway. Gene sets from pathway databases (canonical pathways) were augmented to include gene lists from the literature (curated pathways). We found eight significant canonical pathways, all related to the cell interface with the extracellular space: focal adhesion, integrins, axon guidance, collagen formation, ECM--receptor interactions, and ECM organization ([Fig. 9 A](#fig9){ref-type="fig"} and [Table S3](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp22}). We found 51 significant curated gene sets, 13 of which we characterized as cancer related ([Fig. 9 B](#fig9){ref-type="fig"} and Table S3). Out of 183 DE genes, 33 were associated with at least three cancer-related gene sets ([Fig. 9 B](#fig9){ref-type="fig"}). We conclude that our data identify a novel set of genes regulated by Twist1 during dissemination that collectively reprogram the extracellular environment and cell interactions with the ECM. Importantly, some of the DE genes have enzymatic activity, are up-regulated in human cancers, and may represent novel targets for inhibiting dissemination ([Fig. 9 B](#fig9){ref-type="fig"} and Fig. S5 B).

![**Significantly enriched pathways relate to cell--matrix adhesion.** Gene set enrichment analysis (GSEA) identified eight significant canonical pathways (A), all related to cell--matrix adhesion and ECM organization, and 51 significant curated gene sets, 13 of which were characterized as cancer related (B). The Circos plots depict DE genes associated with each gene set. PID, Pathway Interaction Database.](JCB_201306088_Fig9){#fig9}

E-cad loss blocks single cell dissemination of Twist1^+^ cells
--------------------------------------------------------------

We observed that Twist1 induced dissemination of cells with membrane-localized E-cad and β-catenin and that Twist1 did not affect E-cad RNA levels. It was therefore possible that E-cad was contributing to Twist1-induced dissemination. Accordingly, we tested whether *E-cad* KD would inhibit single cell dissemination. We used lentiviral shRNA and puromycin selection to knock down *Luciferase* (*Luc*) or *E-cad* in *CMV::rtTA;TRE-Twist1* organoids isolated from the same mouse ([Fig. 10 A](#fig10){ref-type="fig"}). We confirmed E-cad loss by immunoblotting ([Fig. 10 B](#fig10){ref-type="fig"}) and used *Luc* KD organoids as a negative control. Consistent with our *E-cad* deletion experiments, we observed a tandem reduction in αE-catenin and β-catenin.

![**E-cad is required for Twist1-induced single cell dissemination.** (A) Organoids from *CMV::rtTA;TRE-Twist1* mice were divided into three groups for treatment with lentiviral shRNA against *Luc* or *E-cad* (two clones). Puromycin was used to select for transduced cells. Organoids were monitored for dissemination after *Twist1* induction. (B) *E-cad* shRNA induced loss of E-cad protein and reductions in αE-catenin and β-catenin. Whole cell lysate samples were loaded for equal protein based on BCA analysis. (C--E) In FGF2-containing medium with doxycycline, *E-cad* KD organoids disseminated significantly fewer cells than *Luc* KD organoids ([Video 8](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp23}). Red arrowheads in C and D indicate disseminated cells. (F) Disseminated cells per organoid were quantified from movies after 100 h of *Twist1* induction. *E-cad* KD significantly reduced single cell dissemination. Box-and-whisker plots are drawn with the box extending from the 25th to 75th percentiles and whiskers at the 10th and 90th percentiles. *n*, number of time-lapse movies; *r*, number of biological replicates. P \< 0.0001 between *Luc* shRNA and *E-cad* shRNA \#1 or \#2; P = 0.014 between *E-cad* shRNA \#1 and \#2 (negative binomial generalized estimating equations model). (G) *E-cad* KD organoids extended collective chains of cells into the matrix (orange arrowheads; [Video 9](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp24}; G' and G''). (H and I) Cells within collective chains stained positive for Twist1 and luminal (K8^+^) and/or myoepithelial (K14^+^) cytokeratins. Bars: (C--E and G) 20 µm; (H and I) 10 µm.](JCB_201306088_Fig10){#fig10}

We next used time-lapse microscopy to quantify dissemination after *Twist1* induction in *Luc* KD and *E-cad* KD organoids. Surprisingly, *E-cad* KD resulted in a strong inhibition of single cell dissemination ([Fig. 10, C--F](#fig10){ref-type="fig"}; and [Video 8](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp25}). Many *Twist1*-induced, *E-cad* KD organoids had no detectable disseminated cells ([Fig. 10 E](#fig10){ref-type="fig"}). Instead, concurrent *Twist1* expression and *E-cad* KD induced migration of long chains of cells into the ECM ([Fig. 10, G--G″](#fig10){ref-type="fig"}; and [Video 9](http://www.jcb.org/cgi/content/full/jcb.201306088/DC1){#supp26}). *Twist1*-induced, *E-cad* KD cells retained nuclear Twist1^+^ protein ([Fig. 10, H and H′](#fig10){ref-type="fig"}), were cytokeratin^+^ ([Fig. 10, I and I′](#fig10){ref-type="fig"}), and were organized in collective groups ([Fig. 10, H--I′](#fig10){ref-type="fig"}). We conclude that Twist1 requires E-cad for efficient single cell dissemination.

Discussion
==========

Our goal was to define the molecular requirements for dissemination of primary, normal epithelial cells. We used genetic techniques to contrast deletion of the cell adhesion gene *E-cad* with expression of the EMT transcription factor *Twist1*. We focused on *E-cad* as it is frequently mutated in human cancer ([@bib10]; [@bib27]), and loss of E-cad can synergize with loss of p53 to promote metastasis ([@bib17]). In our experiments, *E-cad* deletion throughout the mammary epithelium resulted in loss of most intercellular junctions, loss of simple epithelial architecture, and inhibition of branching morphogenesis. However, E-cad^+^ cells within genetic mosaic epithelium were able to initiate and elongate normal mammary buds in 3D culture and in vivo. The associated E-cad^−^ cells were viable and remained adherent to each other but did not contribute to polarized luminal ducts. Therefore, mammary epithelial cells must be able to maintain contact through alternate adhesion systems such as desmosomal cadherins or protocadherins. We conclude that E-cad is required for normal mammary development but that its loss alone is not sufficient for robust dissemination.

We next evaluated the consequences of *Twist1* expression as Twist1 can regulate multiple aspects of metastasis and is thought to function primarily through *E-cad* repression ([@bib61]; [@bib45]; [@bib57]; [@bib53]; [@bib55]). Our data reveal that *Twist1* expression is sufficient to induce normal epithelial cells to disseminate out of an epithelium, migrate through the ECM, and establish secondary epithelial sites. Surprisingly, the disseminating cells retained cytokeratin expression, and many displayed membrane-localized E-cad and β-catenin. Transcriptional profiling revealed essentially no changes in the RNA expression of epithelial-specific cadherins, catenins, or keratins. Instead, Twist1 regulated many genes that mediate cell--matrix adhesion or modify the extracellular compartment. Because Twist1 regulates distinct targets depending on its bHLH dimer partner ([@bib6]), it is likely that its regulated genes vary in different experiments. However, because our experimental induction of *Twist1* was sufficient to induce dissemination, our 183 DE genes are likely particularly important in regulating the transition from adherent to motile epithelial cell phenotypes.

The conceptual framework for EMT was developed in response to classic experiments by Hay and co-workers in which definitive epithelial tissues lost polarity and disseminated as single cells into collagen I gels ([@bib23]; [@bib25]). The appearance of these cells was most similar to that of embryonic mesenchymal cells, leading to the concept of an EMT. We are observing a similar migration of cells out of an epithelial tissue and into the surrounding ECM. However, we do not observe a loss of epithelial-specific gene expression, and the migratory cells are readily able to reestablish epithelial organization, both spontaneously and after cessation of *Twist1* expression. Interestingly, we observed reductions in protein but not RNA levels of E-cad, β-catenin, and αE-catenin, suggesting posttranslational regulation of adherens junction components after *Twist1* induction ([@bib48]). However, we demonstrated that complete KD of *E-cad* dramatically inhibited Twist1-induced single cell dissemination. We speculate that the exact protein levels of E-cad may critically regulate whether *Twist1* expression results in single cell dissemination or collective cell migration.

Accordingly, our data support the concept of a Twist1-dependent epithelial migratory program rather than a transition to mesenchymal cell fate or gene expression. Consistent with this framework, Twist1 regulates genes important for interactions with the stromal ECM environment. Our concept of an epithelial migratory program also finds support in breast cancer. Human breast tumors can express *E-cad* in both the primary tumor and in distant metastases ([@bib29]), and primary breast tumor cells positive for the EMT transcription factor Slug can express high levels of E-cad ([@bib15]).

Most cancer therapies target the increased proliferation of cancer cells relative to normal tissues and not the cell behaviors driving invasion, dissemination, and metastasis. Few of these drugs have proven clinical benefit in metastatic breast cancer patients ([@bib14]). *Twist1* is overexpressed in multiple metastatic human cancers and appears to specifically regulate metastatic cell behaviors in multiple experimental cancer models ([@bib61]; [@bib36]; [@bib53]; [@bib55]). Twist1 therefore represents an attractive conceptual target for developing anti-metastatic therapies. However, it is very difficult to target a transcription factor with small molecule therapeutics. Our observation that Twist1 regulates many proteins in the extracellular compartment suggests that there may be essential, druggable effectors downstream of Twist1 whose repression could inhibit dissemination. Our inducible mouse model revealed that disseminated single cells rapidly cease migration after loss of *Twist1* expression, suggesting that interfering with the Twist1 program could be an effective anticancer strategy. We envision our Twist1-induced dissemination assay as a rapid, reproducible, and scalable platform to build a new molecular model for effectors of Twist1 and to identify novel therapeutic compounds to antagonize cancer invasion and dissemination.

Materials and methods
=====================

Mouse strains
-------------

The *R26::Cre-ER* mouse line ([@bib5]) was a gift from J. Nathans (Johns Hopkins University, Baltimore, MD). The *CMV::rtTA* transgenic line was a gift from F. Cong and H. Varmus (National Cancer Institute, Bethesda, MD). The *Twist1-tetO~7~-luc* (*TRE-Twist1*) transgenic line was previously described ([@bib53]). *E-cad^fl/fl^* ([@bib13]), *mT/mG* ([@bib38]), and *R26::Lox-Stop-Lox-rtTA-IRES-EGFP* (*R26::LSL-rtTA*; [@bib8]) mouse lines were acquired from The Jackson Laboratory. Mouse husbandry and procedures were all conducted under an Institutional Animal Care and Use Committee--approved animal protocol.

Isolation and 3D culture of primary mammary epithelial organoids
----------------------------------------------------------------

We used mechanical disruption, collagenase/trypsin digestion, and differential centrifugation to purify fragments of primary mammary epithelial ducts, termed organoids, as previously described ([@bib20], [@bib22]; [@bib42]). In brief, mammary glands were harvested from mice 8--12 wk old, minced with a scalpel, and shaken for 40 min at 37°C in collagenase solution: DMEM (10565--018; Gibco) with 2 mg/ml collagenase (C2139; Sigma-Aldrich), 2 mg/ml trypsin (27250--018; Gibco), 5% FBS (F0926; Sigma-Aldrich), 5 µg/ml insulin (I9278; Sigma-Aldrich), and 50 µg/ml gentamicin (15750; Gibco). Suspensions were centrifuged at 1,250 rcf to remove a floating layer of adipocytes, and pellets were treated with 2 U/µl DNase (D4263; Sigma-Aldrich) to detach organoids from stromal cells. Enzymes and single cells were removed by four quick spins at 1,250 rcf such that the final pellet consisted mostly of organoids, each containing several hundred cells. Organoids were embedded in 3D Matrigel (354230; BD) at 2--3 organoids/µl and plated as 100-µl suspensions in 24-well coverslip-bottomed plates (662892; Greiner Bio-One) over a 37°C heating block. Gels were allowed to polymerize for 30 min at 37°C and then cultured in organoid medium: DMEM with 1% insulin-transferrin-selenium (51500--056; Gibco) and 1% penicillin-streptomycin (P4333; Sigma-Aldrich). Basal organoid medium was used to induce cyst formation, whereas addition of 2.5 nM FGF2 (F0291; Sigma-Aldrich) was used to induce branching morphogenesis. Branching was scored as organoids with three or more elongated buds. Cysts were scored as unbranched organoids with lumens detectable by light microscopy. Dissemination was scored as organoids with one or more adjacent single cells that were clearly separated from the epithelial group.

Tamoxifen-inducible Cre-mediated deletion in 3D culture
-------------------------------------------------------

Cre activity was induced in *Cre-ER;E-cad^fl/fl^;mT/mG* epithelium by culturing organoids overnight with 50 nM tamoxifen once embedded in Matrigel. To wash out tamoxifen, samples were rinsed with PBS, incubated in organoid medium for 20 min at 37°C, and then cultured in fresh organoid medium. The tamoxifen-inducible system resulted in Cre activity in almost all cells and did not affect branching morphogenesis in control organoids (e.g., *Cre-ER;E-cad^fl/+^;mT/mG*).

Adenoviral delivery of Cre recombinase
--------------------------------------

Before embedding in Matrigel, mammary organoids were infected with Adeno-Cre (1045; Vector Laboratories) at a ratio of ∼10^7^ PFU per 1,000 organoids. Infections were conducted in 50 µl DMEM for 1--2 h at 37°C to yield recombination in 50--75% of cells. Percentage of recombination was raised by increasing viral titer or by overnight incubation with virus.

*Twist1* activation in 3D culture
---------------------------------

*Twist1* expression was induced in 3D Matrigel cultures by supplementing organoid medium with 5 µg/ml doxycycline (Shanghai RenYoung Pharmaceutical Co., Ltd). Because doxycycline is labile, medium was replaced every 48 h. To turn *Twist1* expression off, doxycycline-containing medium was removed and samples were rinsed with sterile PBS. Samples were then incubated with organoid medium without doxycyline for 20 min at 37°C. This medium was then discarded, samples were rinsed again with PBS, and fresh organoid medium without doxycycline was added back.

Mammary fat pad transplantation
-------------------------------

For transplantation of genetic mosaic E-cad or Twist1 tissue, we isolated organoids, induced recombination with Adeno-Cre, and washed organoids twice with 500 µl DMEM to remove viral particles. For all experiments, organoids were incubated at 37°C overnight in organoid medium with 2.5 nM FGF2 in HydroCell 96-well microplates (174907; Thermo Fisher Scientific). For Twist1 experiments, organoid medium was supplemented with 5 µg/ml doxycycline. The next day, organoids were resuspended in a 50% DMEM/50% Matrigel solution at a density of 20--40 organoids/µl and stored on ice. We conducted orthotopic transplantation into 3-wk-old NOD/SCID mice in a sterile hood. In brief, mice were anesthetized with 2--2.5% isoflurane and immobilized, and the surgical site was cleaned with ethanol. A 1-cm incision was made at the midline and a 0.5-cm incision was made from the midline to one hip. The skin was retracted to expose the no. 4 mammary gland. The no. 5 mammary fat pad and the region of the no. 4 mammary fat pad proximal to the lymph node were removed. The organoid suspension was loaded into a syringe (702RN \[7636--01\]; Hamilton; custom 1-in needles, 26 gauge), and 10--20 µl were injected into the cleared no. 4 fat pad. The skin was then locally infiltrated with 5--10 µl of 0.25% bupivacaine. The same procedure was repeated for the contralateral mammary gland. For each mouse, we transplanted control organoids (e.g., *mT/mG*) in one gland and experimental organoids (*E-cad^fl/fl^;mT/mG*, *Cre-ER;E-cad^fl/fl^;mT/mG*, or *R26::LSL-rtTA;TRE-Twist1;mT/mG*) in the other. The surface of the peritoneum was wet with PBS (without Ca^2+^ and Mg^2+^), and wounds were closed with 9-mm autoclips. Triple antibiotic ointment was applied to the incision site as needed. For Twist1 experiments, i.p. injections of 100 µg doxycycline in PBS (without Ca^2+^ and Mg^2+^) were also performed at the time of surgery. *Twist1* activation in vivo was maintained with doxycycline feed (TD.01306; Harlan Laboratories). For deletion of *E-cad* in mature ductal networks, *Cre-ER;E-cad^fl/fl^;mT/mG* organoids were transplanted into NOD/SCID mice and allowed to grow for 6 wk. To induce *E-cad* deletion, we injected tamoxifen i.p. every other day for 5 d (three total injections) using a 1-ml syringe and a 30G1/2 needle (305106; BD). Each injection consisted of 100 µl of 10 mg/ml tamoxifen dissolved in sunflower seed oil. Glands were harvested 2--6 wk after injection.

Differential interference contrast (DIC) microscopy
---------------------------------------------------

Time-lapse imaging of mammary organoids was conducted using an LD Plan-Neofluar 20×/0.4 Korr Ph2 objective lens and a Cell Observer system with an AxioObserver Z1 and an AxioCam MRM camera (Carl Zeiss). In general, we recorded 100--200 positions in parallel for 5--7 d, with images acquired at 20-min intervals. Temperature was maintained at 37°C and CO~2~ at 5%. AxioVision (Carl Zeiss) was used to acquire and analyze time-lapse movies, place scale bars, and export individual TIFFs. Photoshop CS5 (Adobe) was used to adjust levels on entire images to maximize image clarity.

Confocal microscopy
-------------------

Confocal imaging was performed on a spinning-disk confocal microscope (Solamere Technology Group Inc.) with an XR/MEGA-10 S30 camera (Stanford Photonics, Inc.), as previously described ([@bib21]; [@bib19]). A Fluar 20×/0.75 objective lens (Carl Zeiss) was used for intermediate magnification images. An LD C-Apochromat 40×/1.1 W Korr objective lens (Carl Zeiss) was used for high magnification single and time-lapse image acquisition, with water and oil used as the imaging mediums, respectively. Acquisition of both fixed and time-lapse images was performed using a combination of μManager ([@bib18]) and Piper (Stanford Photonics, Inc.). For time-lapse imaging, images were collected at 20-min intervals for 2--4 d, and temperature was maintained at 37°C and CO~2~ at 5%. Imaris (Bitplane) was used to analyze time-lapse movies, place scale bars, and export individual TIFFs. Photoshop CS5 was used as needed to adjust levels and gamma for each channel on entire images to maximize image clarity.

High-pressure freezing and freeze substitution processing
---------------------------------------------------------

We isolated epithelium from *E-cad^fl/fl^* and *E-cad^fl/+^* littermates, induced recombination with Adeno-Cre, and cultured organoids for 5--7 d in Matrigel. Embedded organoids were then fixed in 3% glutaraldehyde to preserve for shipping to Lawrence Berkeley National Laboratory. There, samples were placed in 1-mm-wide by 200-µm-deep aluminum freezing hats and, before freezing, were surrounded with 20% BSA, used as a cryoprotectant. Samples were then cryoimmobilized using a high-pressure freezer (HPM-010; Bal-tec, Inc.) and freeze substituted in 1% osmium tetroxide and 0.1% uranyl acetate in acetone with 5% DDH~2~O, as previously described ([@bib34]). Upon completion of freeze substitution, samples were progressively infiltrated with an epon-Araldite resin ([@bib33]). Polymerization in epon-Araldite resin was performed by flat embedding between two glass slides to allow for precise localization of features of interest ([@bib37]).

TEM
---

Samples were sectioned into 70--100-nm-thin and 500-nm-thick sections using an Ultramicrotome (UC6; Leica). Sections were then collected onto formvar-coated, rhodium-enforced copper 2-mm slot grids. The grids were post-stained with 2% uranyl acetate followed by Reynold's lead citrate, for 5 min each. The sections were imaged using a Tecnai 12 TEM (FEI), operated between 690× and 11,000× at 120 kV under normal conditions. Images were recorded using an Orius SC1000B CCD with Digital Micrograph 3 software (Gatan Inc.). Serial electron microscopy software was used to collect wide-field montages for overview TEM images of complete organoid cross sections ([@bib32]). ImageJ software ([@bib1]) and Photoshop CS4 were used to crop images, place scale bars, and adjust brightness and contrast on entire images, as needed.

Desmosome quantification
------------------------

Desmosomes were counted among basally positioned cells in five *E-cad^fl/fl^* organoids and four *E-cad^fl/+^* organoids imaged by TEM. For each organoid, we selected one to four regions of 20--30 cells that were no more than two cells deep from the organoid--ECM interface. Regions were free of single file columns or epithelial buds. For desmosomes located between cells in the second and third layers deep to the surface, we counted the desmosome but not the third-layer cell. Photoshop CS4 was used to track the desmosomes and regions used for quantification.

Immunofluorescence
------------------

Organoids grown in 3D Matrigel were fixed in 4% paraformaldehyde for 10 min, rinsed three times in PBS for 10 min, embedded in Optimal Cutting Temperature compound (OCT), and frozen at −80°C. OCT blocks were sectioned at 50-µm thickness by cryostat at −20°C. Sections were placed on Superfrost Plus Gold microscope slides (15-188-48; Fisherbrand) and stored at −80°C. For antibody staining, samples were thawed at room temperature, rinsed twice in PBS for 10 min to remove OCT, permeabilized with 0.5% Triton X-100 for 1 h, and rinsed twice in PBS for 10 min. Samples were blocked for 1--3 h with 10% FBS/1% BSA, incubated with primary antibodies overnight at 4°C in 1% FBS/1% BSA, and rinsed three times in 1% FBS/1% BSA for 15 min. Incubation with secondary antibodies was conducted in 1% FBS/1% BSA overnight at 4°C or for 2 h at room temperature. Slides were rinsed three times in PBS for 10 min, mounted with Fluoromount (F4680; Sigma-Aldrich), and sealed with coverslips. F-Actin was stained with Alexa Fluor Phalloidin (1:100; Invitrogen), and nuclei were stained with DAPI (1:1,000; D3571; Invitrogen). Immunofluorescence staining for each antibody was performed at least three independent times for a minimum of 10--15 organoids. Primary antibodies used were rat anti--E-cad (1:250; 13-1900; Invitrogen), rabbit anti--ZO-1 (1:500; 40-2300; Invitrogen), rabbit anti--β-catenin (1:1,000; C2206; Sigma-Aldrich), mouse anti--αE-catenin (1:100; ALX-804-101; Enzo Life Sciences), rabbit anti--laminin 332 (1:1,000; gifts of P. Marinkovich, Stanford University, Stanford, CA, and M. Aumailley, University of Cologne, Cologne, Germany), rat anti--cytokeratin-8 (1:100; TROMA-I; Developmental Studies Hybridoma Bank), rabbit anti--cytokeratin-14 (1:500; PRB-155P; Covance), mouse anti-smooth muscle α-actin (1:250; A5228; Sigma-Aldrich), and mouse anti-Twist1 (1:50; sc-81417; Santa Cruz Biotechnology Inc.). Secondary antibodies used were all Alexa Fluor--conjugated antibodies (1:200; Invitrogen).

Transplanted no. 4 mammary glands were dissected, fixed in 4% paraformaldehyde for 4 h at room temperature, rinsed three times in PBS for 15 min, and embedded in OCT. OCT blocks were sectioned at 50--100-µm thickness by cryostat with OT at −40°C and CT at −30°C. Samples on slides were stained as above but incubated in primary antibody for 48 h at 4°C and in secondary antibody for 24 h at 4°C or for 6--8 h at room temperature.

Protein extraction
------------------

Lysis buffer for protein extraction was prepared by diluting 10× RIPA buffer (20--188; EMD Millipore) in ultrapure water and chilling the mixture at 4°C for at least 2 h. Immediately before use, lysis buffer was supplemented with 0.1% SDS, 5% glycerol, 3 mM EDTA, 1 mM NaF, 1 mM PMSF, 1.5 mM NaVO~4~, Aprotinin (A6279; Sigma-Aldrich), and a mini protease inhibitor tablet (11836153001; Roche). Organoids embedded in 3D Matrigel were collected using freshly made PBS/EDTA buffer (5 mM, 1 mM NaVO~4~, 1.5 mM NaF, and 1 mM PMSF in PBS). Medium was aspirated from 3D culture wells, and all wells were rinsed once quickly with 1 ml of cold PBS. Approximately 1 ml of cold PBS/EDTA buffer was used to dissolve two 100-µl gels. Solutions were transferred to centrifuge tubes and mixed well by pipetting. Tubes were left on a 4°C shaker for 1 h to dissolve the Matrigel and then centrifuged at 400 rcf for 5 min at 4°C. Supernatants were removed and, if necessary, pellets were washed with additional PBS/EDTA to remove residual Matrigel. After another 5-min spin, pellets were resuspended in 100 µl of RIPA lysis buffer, vortexed, and left on ice for 30--40 min. Tubes were centrifuged for 10 min at 18,400 rcf at 4°C and supernatants transferred to new centrifuge tubes and stored at −80°C. For lentivirus experiments, organoids were collected after 3-d puromycin selection, washed once with cold PBS to remove trace medium, and resuspended in RIPA lysis buffer as described.

Western blotting
----------------

Whole cell protein lysates were thawed on ice for 20 min, vortexed, and centrifuged for 5 min at 18,400 rcf at 4°C. Samples in Laemmli sample buffer (161--0747; Bio-Rad Laboratories) and β-mercaptoethanol were heated at 70°C for 10 min and loaded for equal protein based on bicinchoninic acid (BCA) analysis (Thermo Fisher Scientific) in 4--15% Mini-PROTEAN TGX precast gels (456--1084; Bio-Rad Laboratories). SDS-PAGE was performed at 40 V for 30 min and 80 V for ∼90 min until the dye front ran off the gels. Gels were transferred onto nitrocellulose membranes (45-000-948; GE Healthcare) at 100 V for 1 h at 4°C. Membranes were blocked with 5% milk in TBST (03-500-537; Thermo Fisher Scientific) for 1 h at room temperature. Primary antibodies were prepared in blocking buffer and added overnight at 4°C. Primary antibodies used were rat anti--E-cad (1:1,000; 13-1900; Invitrogen), rabbit anti--β-catenin (1:2,000; C2206; Sigma-Aldrich), mouse anti--αE-catenin (1:1,000; ALX-804-101; Enzo Life Sciences), rabbit anti--N-cad (1:1,000; ab18203; Abcam), mouse anti-Twist1 (1:500; sc-81417; Santa Cruz Biotechnology, Inc.), and mouse anti--β-actin (1:1,000; A2228; Sigma-Aldrich). The N-cad antibody detected protein by Western blotting but not by immunofluorescence. Membranes were washed three times with TBST for 5 min and incubated with HRP-conjugated secondary antibodies (1:2,000; Invitrogen) in blocking buffer for 1 h at room temperature. Bands were detected with ECL reagents (34075 or 34095; Thermo Fisher Scientific), and membranes were imaged using an imager and software (Alpha-InnoTec). Band intensities acquired under autoexposure were quantified using Fiji. To probe for more than one protein, membranes were incubated with stripping buffer (21059; Thermo Fisher Scientific) for 30 min at 37°C, washed three times with TBST for 5 min, and reblocked. Primary antibodies used on the same membrane were from different hosts.

*E-cad* KD experiments
----------------------

Approximately 1,000 *CMV::rtTA;TRE-Twist1* organoids resuspended in 200 µl of basal organoid medium were added to each of four wells of a HydroCell 96-well microplate. Organoids were allowed to settle for 1 h at 37°C. Lentiviral transduction particles were thawed on ice: (1) MISSION pLKO.1-puro *Luciferase* shRNA (10^6^ TU/ml; SHC007V; Sigma-Aldrich); (2) MISSION pLKO.1-puro *Cdh1* shRNA \#1 (10^6^ TU/ml; TRCN0000042578; Sigma-Aldrich); (3) MISSION pLKO.1-puro *Cdh1* shRNA \#2 (10^6^ TU/ml; TRCN0000042581; Sigma-Aldrich). In separate centrifuge tubes, 3 µl of ViroMag R/L nanoparticles (RL40200; OZ Biosciences) were mixed with 47 µl of lentivirus and incubated at room temperature for 30 min. In three of the organoid wells, 150 µl of medium were carefully removed, and 50 µl of the ViroMag/lentivirus mix were added. Suspensions were mixed well to disperse the organoids and prevent aggregation. The fourth organoid well served as a no-virus, puromycin control to evaluate killing efficiency. The 96-well plate was incubated on top of a magnetic plate (MF10000; OZ Biosciences) at 37°C for 1.5 h and then taken off the magnet and incubated overnight at 37°C. On day 2, ∼70 µl of medium were removed from each well with virus, 200 µl of fresh organoid medium were added, and the suspensions were mixed well to redisperse the organoids. On day 3, ∼200 µl of medium were removed from all wells, and 200 µl of organoid medium with 2.5 nM FGF2 and 4 µg/ml puromycin were added. Selection was performed for 3 d, and the surviving virus-treated organoids were collected for 3D culture and imaged by DIC time-lapse microscopy. In parallel, *TRE-Twist1* (rtTA^−^) organoids from littermate controls were treated with lentiviruses and, after selection, used for protein extraction to evaluate *E-cad* KD efficiency. Time-lapse movies were used to track and count cells that had disseminated by 100 h of *Twist1* induction in each of the three treatment groups. A cell was considered disseminated if it had a clear space between itself and the main organoid (visible ECM) and was observed to be migrating away persistently. Cells within collective chains that temporarily detached in only a few frames were not counted as disseminated.

RNA isolation and sequencing
----------------------------

Organoids were isolated from three *CMV::rtTA;TRE-Twist1* mice ("Twist1") and three *TRE-Twist1* (rtTA^−^; "Control") littermates (all inbred FVB/N). For each mouse, organoids were embedded in 3D Matrigel at 3--10 organoids/µl and plated as six 50-µl suspensions in a 35-mm dish. Organoids were cultured in basal organoid medium for 24 h and in basal organoid medium supplemented with 5 µg/ml doxycycline for an additional 48 h. All *CMV::rtTA;TRE-Twist1* samples were disseminating at 48 h of *Twist1* induction, whereas no control samples were disseminating. Total RNA was extracted using 1 ml of TRIzol per dish (15596-026; Life Technologies) and RNeasy (QIAGEN). With 10--100 ng of RNA collected per sample, we generated barcoded NuGen RNA-seq v.2 libraries and ran paired end, 75-bp, 50-cycle sequencing on a HiSeq 2000 (Johns Hopkins Medical Institutions Deep Sequencing and Microarray Core Facility).

Paired-end, non-strand--specific RNA-seq reads were mapped to the mouse reference genome (Genomic Reference Consortium build 38) using read mapper Bowtie ([@bib30]) and splice junction mapper TopHat ([@bib54]). We achieved a mean of 51.4 million uniquely mapped reads per sample and estimated the number of reads mapped to each gene using HTSeq ([@bib2]), with gene coordinates from the reference genome Generic Feature Format file. Raw counts were normalized and p-values were calculated for Twist1 versus control differential expression from negative binomial distributions using DESeq ([@bib3]). Based on the number of genes tested, the genome-wide significance level for 0.05 family-wise error rate was 2.74 × 10^−6^, and 183 genes were significant at this level. Sequence data has been uploaded to the Sequence Read Archive (project accession no. SRP033275).

GO analysis
-----------

Significant genes were characterized using GO Slim categories for biological process, cellular component, and molecular function ([@bib4]; GO file downloaded on 9/12/13 and mapping from 3/5/13). We first computed the overall fraction of genes that were up-regulated (*f*~up~ = 107/18,260) and down-regulated (*f*~down~ = 76/18,260). For each GO term, we then calculated the number of genes *n* annotated to the category and also among the 18,260 genes sequenced. Categories with *n* \< 2 were not considered further. For categories with *n* ≥ 2, we conducted separate two-sided tests corresponding to enrichment or depletion based on Poisson distributions for up-regulated (expected number = *f*~up~*n*) and down-regulated (expected number = *f*~down~*n*) DE genes. For each of the three ontologies, the p-value threshold for 0.05 family-wise error rate was set to 0.05/(4 × number of categories tested). This conservative approach was selected as more computationally convenient than the corresponding Fisher's exact tests.

Pathway-level differential expression
-------------------------------------

To assess pathway-level differential expression, we used gene sets available through MSigDB v4.0 ([@bib50]). The 1,320 canonical gene sets within MSigDB are aggregated from major pathway databases: BioCarta, KEGG, Reactome, the Pathway Interaction Database, the Sigma-Aldrich database, the Signaling Gateway database, the Signal Transduction KE database, and the SuperArray database. These are then augmented to 4,722 curated gene sets by including gene lists from published studies, the L2L gene sets from mammalian microarray studies ([@bib40]), the MYC Target Gene Database ([@bib62]), and other public resources. For each gene, including genes not differentially expressed at genome-wide significance, the p-value from DESeq was converted to the equivalent *z*-score for a two-sided test, with *z* \> 0 for Twist1 \> Control and *z* \< 0 for Twist1 \< Control. Each pathway was tested using a one-sided Student's *t* test of \|*z*\| within pathway \> \|*z*\| outside pathway, corresponding to an increased number of DE genes without regard to direction (up or down in Twist1 versus Control). Significance thresholds for 0.05 family-wise error rates at the pathway level were estimated using 500 permutations of gene *z*-scores, recording the best p-value from each permutation, and taking the 25th-best p-value as the 0.05 FWER threshold. The resulting thresholds were 1.44 × 10^−13^ for canonical gene sets and 5.31 × 10^−19^ for curated gene sets. These thresholds are more stringent than a standard Bonferroni correction.

Online supplemental material
----------------------------

Fig. S1 shows that *E-cad* deletion results in complete loss of E-cad protein and reduced levels of other adherens junction components in 3D culture and in vivo. Fig. S2 shows that Twist1-induced dissemination is cell autonomous and occurs in vivo. Fig. S3 shows that *Twist1* expression results in reduced levels of adherens junction proteins. Fig. S4 shows heat maps of genes directly associated with relevant GO Slim biological process and cellular component terms. Fig. S5 shows the mapped GO Slim molecular function terms and a heat map of Twist1-regulated genes with enzymatic activity. Video 1 shows confocal time-lapse imaging of a *Cre-ER;E-cad^fl/fl^;mT/mG* organoid transitioning from simple to multilayered organization after *E-cad* deletion. Video 2 shows DIC time-lapse imaging of representative E-cad^+^ and E-cad^−^ organoids grown in the branching morphogenesis assay. Video 3 shows confocal time-lapse imaging of E-cad^+^ bud initiation in a genetic mosaic *E-cad^fl/fl^;mT/mG* organoid. Videos 4 and 5 show DIC time-lapse imaging of representative *CMV::rtTA;TRE-Twist1* organoids grown in basal medium and FGF2-containing medium, respectively, with and without *Twist1* induction. Videos 6 and 7 show DIC time-lapse imaging of a *CMV::rtTA;TRE-Twist1* organoid grown in basal medium and FGF2-containing medium, respectively, with transient *Twist1* induction. Video 8 shows DIC time-lapse imaging of representative *Twist1*-expressing organoids with *Luc* and *E-cad* KD. Video 9 shows DIC time-lapse imaging of collective epithelial migration in a *Twist1*-expressing, *E-cad* KD organoid. Table S1 lists all genes sequenced by RNA-seq, sorted by p-value, and the 183 DE genes along with their associated GO Slim terms. Table S2 lists RNA-seq raw counts and p-values for 127 epithelial genes involved in cell--cell adhesion and intercellular junctions. Table S3 lists the significant canonical pathways and curated gene sets identified by gene set enrichment analysis. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201306088/DC1>.
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